Earnings call transcript: Scandi Standard’s stock soars 199% post-Q1 2026 results

Scandi Standard reported strong Q1 2026 results, with net sales up 9% and EBIT up 35% to SEK 151 million, driving a 199.44% stock surge. EBIT margin improved by 90 bps and EBIT per kilo rose 29% to SEK 2.22, though Ready-to-Eat remains a short-term margin drag due to maintenance and delayed cost pass-through. Management reiterated a positive 2026 outlook, with continued improvement investments and stable-to-improving demand across channels.

Analysis

The market is rewarding a classic operating-leverage story, but the second-order effect is more interesting: management is effectively using RTC strength to subsidize an RTE reset. That matters because the business mix is shifting toward higher-return, more controllable volume, while the lower-margin segment is temporarily suppressed by input mismatch and timing, creating a setup for margin catch-up over the next 2-3 quarters if pricing discipline holds.

The bigger winner is likely not the obvious poultry peers alone, but the company’s upstream and adjacent service ecosystem: feed, logistics, packaging, and regional cold-chain capacity should see better utilization if this demand trend persists. The flip side is that competitors with less integrated sourcing will feel pressure first, because they cannot as easily re-optimize product mix when raw-material economics move against them. That should widen share gaps in fragmented Nordic poultry faster than consensus expects.

The main risk is that the move has likely outrun near-term fundamentals: a near-tripling of the stock embeds a lot of faith in smooth capacity ramp, pass-through, and no feed-cost shock. If fertilizer/feed inflation hits with a lag into late 2026, the first-order damage may show up in RTE pricing before RTC can fully reprice, which would compress the implied recovery path. This is a months, not days, story: near-term sentiment can stay hot, but the key catalyst will be whether Factory C starts contributing without a working-capital or execution hiccup.

Contrarian read: the consensus is probably underestimating how much of the current uplift is cyclical versus structural. The structural protein substitution trend is real, but the stock now appears to be pricing a clean 2026-27 re-rating despite execution and input-cost asymmetry still unresolved. I’d fade the most aggressive continuation view and instead express it as a relative value trade versus a less operationally leveraged staple or food producer.

Key Decisions for Investors

• Take profits on the recent move via a partial trim or covered-call overwrite on Scandi Standard-equivalent exposure; 3-6 month risk/reward is skewed by sentiment multiple expansion more than earnings revisions.
• Pair long a Nordic poultry/protein operator with short a less integrated European packaged-food name that lacks pricing flexibility; thesis should play out over 2 quarters if RTC out-earning persists.
• Add on pullbacks only after the next quarterly read-through confirms RTE recovery and no working-capital spike from capacity ramp; use a 10-15% retracement as entry, not strength chasing.
• For higher-conviction upside, use call spreads rather than outright equity to capture another leg if Factory C ramps cleanly; 6-9 month horizon with defined downside.
• Hedge the bull case with a short basket of feed-sensitive agribusiness/input names if fertilizer and grain costs begin inflecting; this protects against the most plausible 2H26 margin reversal.